biogen inc (IDP:German Stock Exchange)
Transactions by BIOGEN INC (IDP) in the last 6 months
Applied Genetic Technologies Corporation (NasdaqGM:AGTC) announced that it has entered into an agreement for a private placement of 1,453,981 common shares with new investor Biogen Inc. at $20.63 per share for gross proceeds of $30,000,000 on July 2, 2015. The transaction is expected to close in the third quarter of 2015.
Biogen Inc. (NasdaqGS:BIIB) announces a share repurchase program. Under the program, the company will repurchase up to $5,000 million worth of its common stock. The repurchased shares will be retired. The share repurchase program does not have an expiration date. The company currently expects that purchases will be executed within a period of up to five years.
The Board of Directors of Biogen Inc. has authorized a buyback plan on May 7, 2015.
On May 7, 2015, the ...
Biogen Idec Inc. (NasdaqGS:BIIB) agreed to acquire Convergence Pharmaceuticals Limited from Apposite Capital LLP, New Leaf Venture Partners, SV Life Sciences Advisers, LLC and others for approximately $680 million in cash on January 11, 2015. Under the terms of the deal, Biogen Idec will pay Convergence shareholders an upfront payment of $200 million and Convergence shareholders will receive additional payments up to $475 million contingent on future milestones. Convergence ...
Apposite Healthcare Fund
New Leaf Venture Partners, L.L.C.
SV Life Sciences Advisers, LLC
SV Life Sciences Fund V
|Bristol-Myers Squibb Co||$67.50 USD||+0.02|
|Celgene Corp||$118.82 USD||-0.70|
|Eli Lilly & Co||$86.35 USD||+0.21|
|Medtronic PLC||$73.53 USD||-0.28|
|Novo Nordisk A/S||kr371.00 DKK||+2.30|
|View Industry Companies|